Welcome to Pharmacogenomics, the definitive journal for the post-genomic era, bringing you news, views and opinions in personalized medicine and genome research, both in print and on the web


Increased frequency: Pharmacogenomics will increase its frequency for 2004 from six to eight issues annually!

Pharmacogenetics and public policy: expert views in Europe and North America.....
David MelzerThe new genetics is stimulating the development of genetic testing of patients to help choose the best drug, adjust doses and avoid side effects. Proponents say that this personalized medicine will revolutionize drug development and healthcare. In a series of group meetings, 48 leading experts from regulatory agencies, industry, academia and consumer interests gave their opinions on the public policy priorities.
An Ethical Perspective article by D Melzer, D Detmer and
R Zimmern 
Also in the November issue of Pharmacogenomics.....
exceptional reviews on: Pharmacogenomics of diuretic drugs, Applications of genomics in the inner ear, Pharmacogenomics in the treatment of epilepsy and much more.........

NEWS HEADLINES

Regulation & ethics 
The debate continues
Major Players
Exclusive Company Profiles

Conference Scene
Expert coverage

Microarray focus 
The hot topic in PGx

Pharmacy and PGx
Revolution or renaissance?
viagra online without prescription
Considerations for pharmacists

 

Priority Papers in BIOINFORMATICS, PROTEOMICS & PHARMACOGENETICS. New! TOP TEN


SUBMIT YOUR ORIGINAL PAPERS!
We offer the fastest route to publication for your primary articles. Pharmacogenomics is indexed by MEDLINE, so you can obtain maximum exposure of your research endeavours..........


PAPER OF THE MONTH........

Genome-wide evaluation of the public SNP databases.

This special report addresses the questions posed by users of the public SNP databases. How many of the SNPs are real? What is the frequency spectrum of the SNPs in these databases? What is the distribution picture of these SNPs across different ethnic and geographical populations? What fraction of the total number of SNPs is already captured by these databases?